BlackRock’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,424,200
| Closed | -$155M | – | 5119 |
|
|
2018
Q4 | $155M | Buy |
5,424,200
+85,905
| +2% | +$2.44M | 0.01% | 1501 |
|
|
2018
Q3 | $149M | Buy |
5,338,295
+48,689
| +0.9% | +$1.37M | 0.01% | 1691 |
|
|
2018
Q2 | $148M | Buy |
5,289,606
+501,922
| +10% | +$13.5M | 0.01% | 1668 |
|
|
2018
Q1 | $119M | Buy |
4,787,684
+390,594
| +9% | +$9.5M | 0.01% | 1719 |
|
|
2017
Q4 | $107M | Buy |
4,397,090
+118,014
| +3% | +$3.11M | 0.01% | 1838 |
|
|
2017
Q3 | $118M | Buy |
4,279,076
+113,060
| +3% | +$3.02M | 0.01% | 1742 |
|
|
2017
Q2 | $104M | Sell |
4,166,016
-247,310
| -6% | -$6.12M | 0.01% | 1769 |
|
|
2017
Q1 | $118M | Buy |
4,413,326
+4,401,851
| +38,360% | +$122M | 0.01% | 1659 |
|
|
2016
Q4 | $301K | Sell |
11,475
-1,240
| -10% | -$30.7K | ﹤0.01% | 1909 |
|
|
2016
Q3 | $318K | Buy |
12,715
+6,416
| +102% | +$150K | ﹤0.01% | 1922 |
|
|
2016
Q2 | $136K | Buy |
6,299
+2,116
| +51% | +$37.8K | ﹤0.01% | 2342 |
|
|
2016
Q1 | $62K | Buy |
4,183
+1,561
| +60% | +$26.2K | ﹤0.01% | 2250 |
|
|
2015
Q4 | $58K | Buy |
2,622
+1,343
| +105% | +$25K | ﹤0.01% | 1971 |
|
|
2015
Q3 | $20K | Sell |
1,279
-312
| -20% | -$5K | ﹤0.01% | 2405 |
|
|
2015
Q2 | $23K | Hold |
1,591
| – | – | ﹤0.01% | 2342 |
|
|
2015
Q1 | $27K | Hold |
1,591
| – | – | ﹤0.01% | 2221 |
|
|
2014
Q4 | $28K | Hold |
1,591
| – | – | ﹤0.01% | 2214 |
|
|
2014
Q3 | $21K | Hold |
1,591
| – | – | ﹤0.01% | 2316 |
|
|
2014
Q2 | $23K | Sell |
1,591
-140
| -8% | -$1.83K | ﹤0.01% | 2307 |
|
|
2014
Q1 | $22K | Hold |
1,731
| – | – | ﹤0.01% | 2323 |
|
|
2013
Q4 | $17K | Hold |
1,731
| – | – | ﹤0.01% | 2456 |
|
|
2013
Q3 | $23K | Hold |
1,731
| – | – | ﹤0.01% | 2213 |
|
|
2013
Q2 | $25K | Buy |
+1,731
| New | +$21.8K | ﹤0.01% | 2195 |
|
Other funds holding NXTM
BlackRock's NXTM Position: Q1 2019 in Review
BlackRock sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 5,424,200 shares — an estimated $155M sold.
BlackRock first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $155M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- BlackRock reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- BlackRock sold 5,424,200 NxStage Medical Inc. shares in Q1 2019, an estimated $155M.
- BlackRock first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- BlackRock's NxStage Medical Inc. position peaked at $155M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on BlackRock's 13F filing for Q1 2019, filed 9 May 2019.